The Role of Whole-Body Positron Emission Tomography With [18F]Fluorodeoxyglucose in Identifying Operable Colorectal Cancer Metastases to the Liver

1996 ◽  
Vol 131 (7) ◽  
pp. 703 ◽  
Author(s):  
David T. M. Lai
Keyword(s):  
Colorectal Cancer ◽  
Positron Emission Tomography ◽  
Emission Tomography ◽  
Whole Body ◽  
18F Fluorodeoxyglucose ◽  
Cancer Metastases ◽  
Positron Emission ◽  
Colorectal Cancer Metastases

scholarly journals The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis

2012 ◽  
pp. 21-26 ◽  
Author(s):  
Silvia Taralli ◽  
Giorgio Treglia ◽  
Alessandro Giordano
Keyword(s):  
Positron Emission Tomography ◽  
Fdg Pet ◽  
Emission Tomography ◽  
Whole Body ◽  
Imaging Method ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
18F Fluorodeoxyglucose ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

IntroductionThe purpose of this article is to examine the emerging role of whole-body positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with sarcoidosis.Materials and methodsWe reviewed the literature on the use of FDG-PET in patients with sarcoidosis to identify how this technique is being applied in clinical practice.Results and discussionOur review shows that: 1) sarcoidosis is commonly associated with increased FDG uptake. Therefore, positive findings should be interpreted with caution when FDG-PET is being used to distinguish benign from malignant abnormalities; 2) FDG-PET seems to be a very useful molecular imaging method for staging sarcoidosis, identification of occult sites of involvement, guiding biopsy procedures, and monitoring patients’ responses to treatment; and 3) in patients with sarcoidosis, the diagnostic accuracy of FDG-PET is superior to that of 67Ga scintigraphy.

Sign in / Sign up

Export Citation Format

Share Document